Form 4 for EIKN Eikon Therapeutics, Inc.
Accepted 2026-09-08 16:33:27 ET · period of report 2026-09-03 · accession 0001193125-26-385268 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-08 16:33 | 2026-09-03 | EIKN | Column Group IV GP, LP | 10% | P - Purchase | $11.56 | +89.2K | 89.2K | New | +$1.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-03 | P | A | 89,200 | $11.56 | 89,200 | I See footnote | — | — | (F1) The price reported in column 4 is a weighted average price. The securities were purchased in multiple transactions at prices ranging from $11.17 to $11.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote. (F2) The securities are directly held by Peter Svennilson. |